Nurofen fined heavily for mis-leading consumers

Another instance of the regulator intervening to protect consumers from exploitation by another pharmaceutical company. In this instance, the manufacturer of Nurofen, Reckitt Benckiser, has seen its fine increase from $1.7m to $6m, for misleading branding of identical products.

My take on this? Don't buy Nurofen in the first place - generic ibuprofen is identical. However, that said, some studies suggest that pricier painkillers are 'better' at providing pain relief - if only because of their psychosomatic effects.